These data support the view that IPP can predict BOO, compared with Qmax, PVR, and PV, for patients with BPH/LUTS, and may have diagnostic predictive value similar to that of pressure–flow UDS [19]. This evidence concerns the gene IPP and benign prostatic hyperplasia.